COMP <GO>
ELA vs NHTC // REVENUE GROWTH (YOY)
Envela Corporation (NYSE) VS. Natural Health Trends Corp. (NASDAQ) • 15-METRIC TALLY: ELA 8
— NHTC 1
▲ REVENUE GROWTH (YOY) LEADER: ELA
LAST: $11.38 (+2.15%) • MKT CAP: $295.5M
revenue-growth
33.60%
LAST: $0.77 (-8.01%) • MKT CAP: $6.6M
revenue-growth
-7.40%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ELA VS. NHTC)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | ELA | NHTC | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 22.40% | 73.50% | -51.10 | NHTC | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 20.70% | -8.60% | +29.30 | ELA | /roic <GO> |
| EV/EBITDA & P/E Valuation | 15.6x | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 0.47% | — | — | TIE | /fcf-yield <GO> |
| Operating Margin | 7.50% | -4.50% | +12.00 | ELA | /operating-margins <GO> |
| Net Profit Margin | 6.10% | -2.20% | +8.30 | ELA | /net-margins <GO> |
| Revenue Growth (YoY) ACTIVE | 33.60% | -7.40% | +41.00 | ELA | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 10.30 | 0.46 | +9.84 | ELA | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 2/9 | +5.00 | ELA | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 35.2 | 31.1 | +4.10 | ELA | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 17.0x | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $295.5M | $6.6M | $288.9M | ELA | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | ELA REV | NHTC REV | ELA GROSS % | NHTC GROSS % | ELA FCF | NHTC FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $241.0M | $39.8M | 22.4% | 73.5% | $1.4M | -$6.1M |
| FY 2024 | $180.4M | $43.0M | 24.6% | 74.0% | $6.7M | -$3.4M |
| FY 2023 | $171.7M | $43.9M | — | — | $5.8M | -$4.3M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ELA // BETA —
NHTC // BETA —